DRUG · Mapped RxNorm record
Baricitinib
Normalized identity: baricitinibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
NCT03915964
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
TNF Inhibitor
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
BaricitinibDRUG · verified · RxNorm: baricitinib
TNF InhibitorDRUG
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Incyte Corporationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03915964 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.